Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity
after allogeneic stem-cell transplantation. Because of the small number of results from well …

Background Macrolide antibiotics (macrolides) are among the most commonly prescribed
antibiotics worldwide and are used for a wide range of infections. However, macrolides also …

Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in
part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung …

Abstract Approximately 35% to 50% of patients otherwise cured of hematologic
malignancies after allogeneic hematopoietic stem cell transplantation will develop the …

Bronchiolitis obliterans syndrome (BOS) may develop after either lung or haematopoietic
stem cell transplantation (HSCT), with similarities in histopathological features and clinical …

Early administration of azithromycin after allogeneic hematopoietic stem cell transplantation
was shown to increase the relapse of hematological malignancies. To determine the impact …

Administration of azithromycin after allogeneic hematopoietic stem cell transplantation for
hematologic malignancies has been associated with relapse in a randomized phase 3 …

Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor
cells into patients with hematologic disorders with the goal of re-establishing normal …

Macrolide antibiotics are one of the most commonly used broad-spectrum antibiotics. They
have an inhibitory effect on a variety of respiratory pathogens; besides, they have non-anti …

Haematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of
malignant and nonmalignant conditions. Pulmonary complications, both infectious and …